Hyphens Pharma International Limited reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was SGD 125.88 million compared to SGD 120.98 million a year ago. Net income was SGD 6.85 million compared to SGD 6.16 million a year ago. Basic earnings per share from continuing operations was SGD 0.0227 compared to SGD 0.0205 a year ago. Diluted earnings per share from continuing operations was SGD 0.0227 compared to SGD 0.0205 a year ago.